Member Info for marve

Someone could always phone finncap and ask if placing still open, if it genuinely is open till 5pm I would be surprised results are out that quick, just because all needs to be be compiled and funds sent and all that would expect

Only stupid ramping here comes from the odd Johnny come lately

Those holding from low prices don't need to ramp, they are confident in the future of GDR, although that confidence probably comes across as ramping to the new folk

2 weeks ago thepunter was very pro GDR when buying in at 140p and just under £50 market cap

At least that what their posting history says

And in my opinion would also not be wasting their time if they did not think they could deliver, it would ruin their reputation if they failed

This is no back street outfit or tin pot business just trying to make a quick buck

They already have a WHO approved product and have relationships with many major industry players, including a separate US government contract

This is why so many people have confidence in GDR

Agree, thanks invest4

We need to keep an eye on that site, I'm sure Cytiva was mentioned on it weeks ago as a possible partnership and then they obviously succeeded in agreeing a partnership

Thanks for the post silkman

That is the key, if Genedrive were just developing more kits of the same they would not stand out, but they went for a world first test, with the plan on being as accurate as any test there is

This is the planned unique selling point (USP) for genedrive

Hence the excitement in what could happen here

Technik, GDR aside, as you seem to know your scientific stuff, what do you make of the affimers and aptamers that other company's are looking to bring to market, not what other company's are doing, just how effective affimers and aptamers can be?

Downside of the western world, the freedom that we take for granted and believe we should have, massive hindrance in this kind of situation

Which is why I don't know why it has been built up as this big announcement, because that gives an expectation there will be some change, don't think there should have been such a demand for an exit strategy either

However I don't get involved in anything political, always had the view, that no matter what the situation, each party still just cares about point scoring against the other

Think what a lot of people are missing, is it is not your typical placing

It was not offered to private investors who could likely just flip them, bar a small 12.5%

It is not simply because the company need working capital and they have nothing on the horizon

Typical placing patterns go out the window

The share price could drift a bit, although I do not expect there to be a massive amount of it

As soon as placing allocation is known, then it should be full steam ahead

The uncertainty of who will receive placing shares, those playing it safe till placing complete, that has generally caused a lot of people to be cautious

However, anybody holding for product launch and market sales, likely won't care about the price in the very short term

GDR:

"It is a high volume laboratory assay compatible with multiple third party platforms and is expected to be able to perform 96 tests in under two hours."

NCYT:

"The test has been designed to run on multiple molecular testing platforms, including Primerdesign's own genesig® q16 and q32 instrument"

"The test can generate a result in less than two hour"

-The q32 means 32 samples

@technik what do you think NCYT max test run every 2 hours is, ignoring the genesig instrument if that is only 32

Per RNS 5th May

"The first test, which is circa three weeks from market"

"The Company anticipates launching the Genedrive® 96-SARS-CoV-2 in May 2020"

For the moment i am not really too bothered about the second test

If the first test starts selling by end of month and significant cash flow starts coming in, then maybe more resources can be put into the second test to speed up getting it to market - in fact that is probably the idea

So if first test hits the ground running it's all good

The change from M&G might well have been a client just changing broker, with Spreadex involved

Calculus also just holds investments on behalf of clients, but they do provide clients with EIS and VCT products to invest in (which could include GDR shares)

The below link will be updated soon as any over 3% shareholder has changes:

http://www.genedriveplc.com/investor-relations/shareholders.php

The uncertainty about antibody testing is good for GDR:

1. How accurate are antibody tests

2. Even if antibody tests are 100% accurate it is not known if having antibodies gives you immunity

M&G went under 5% and Spreadex at same time went above 5%, the transaction on 5 Feb 2020 had to involvement both of them

The comparison with NCYT is to give some sort of an idea of what GDR could become if it makes the progress we hope it does

History of company shows they usually get loan note and bond holders on board who are in it for the long term, placings are now something GDR do

Why did they do it, more than likely they decided that time was of the essence and a placing was better than continuing to seek other sources of funding, there will be hundreds probably thousands of businesses trying to claim government grants saying they can help, so backlog would be long, this was even said in a 5pm daily meeting, because same thing is happening with businesses coming forward saying we can supply PPE

Done my research, paid my money, taken my chance, I would not be holding shares if I did not think GDR had a very bright future

The fact they were able to secure £8m of funding so quick suggests to me that the risk of not getting the CE mark is very low, the risk of not getting their test to market is very low, the risk of the test not being in demand is very low

If you want to call GDR a speculative investment at the moment then fair enough, I won't argue that because people have different views on risk

Liverpool could still not win the premier league title, but if I was given odds of even money on them winning it, I would be all over it

GDR is like anything, all about risk versus reward, and my belief is the reward massively outweighs the risk, hence I'm holding

For anyone not comfortable with risk and volatility, then this investment is not currently appropriate for you

But for anyone that is currently questioning their original support for GDR, I would read the placing rns, in particular the detailed specifics

Then whatever your view is come Monday morning, go with it

Then I think you have turned up at the right time valuefinder

If GDR succeeds in the next step of having he product available and the demand is there then it is potentially a few hundred million pound company in the making, so a few bags from current position

Still not said why you are here, why not answer the question, or just have something to hide

If GDR were already selling 6m tests a month their share price and market cap would be far far far higher, but that is investing, GDR have no yet reached that point but that is the aim

You pay your money you take your chance

No won't enter reasonable discussion, so out of respect for all the genuine posters and readers, I will no longer clog up this board with replies to you

Valuefinder

People can post where they want, your name was not familiar on here so I wondered what history you had and saw you had a lot of posts on NCYT

Are you invested in GDR? Actively shorting it? Only here to flip placing shares?

Nothing wrong with fair discussion, as long as people state there reason for being here